title: Polypharmacy and potentially inappropriate medication in the adult, community-dwelling population in Switzerland.
abstract: BACKGROUND
  Polypharmacy and potentially inappropriate medication (PIM) are associated with adverse outcomes such as hospitalization, loss of productivity, and death.
  
  
  OBJECTIVE
  This study evaluates the prevalence of polypharmacy and PIM in the adult community-dwelling population in Switzerland.
  
  
  METHODS
  The analysis is done based on claims data from the largest health insurance in Switzerland. We calculated the number of medications submitted for reimbursement, the proportion of persons with polypharmacy, and the proportion of persons receiving PIM according to the 2003 Beers criteria and the PRISCUS list. Additionally, we estimated cost for medications and PIM, and identified the most prevalent groups of PIM according to the Anatomical Therapeutic Chemical Classification System (ATC).
  
  
  RESULTS
  17 % of the adult community-dwelling population in Switzerland received 5 or more medications which is one of the common definitions of polypharmacy, and over 21 % of adults aged more than 65 years had a PIM according to 2003 Beers criteria or the PRISCUS list. The most prevalent classes of PIM were psycholeptics, sex hormones, psychoanaleptics, and antiinflammatory drugs.
  
  
  CONCLUSIONS
  Although the present study has a number of limitations, we conclude that the prevalence of polypharmacy and PIM in Switzerland is high. A broad spectrum of interventions on the individual level as well as on the population level is urgently needed.
authors.affiliation: Swiss Center for Telemedicine Medgate, Basel, Switzerland. eva.blozik@medgate.ch
authors.forename: Eva
authors.initials: E
authors.lastname: Blozik
authors.forename: Roland
authors.initials: R
authors.lastname: Rapold
authors.forename: Jan
authors.initials: J
authors.lastname: von Overbeck
authors.forename: Oliver
authors.initials: O
authors.lastname: Reich
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008297:Male; D008508:Medication Errors / Q000191:economics / Q000706:statistics & numerical data*; D008875:Middle Aged; D019338:Polypharmacy; D010818:Practice Patterns, Physicians' / Q000191:economics / Q000706:statistics & numerical data; D015995:Prevalence; D012111:Residence Characteristics; D013557:Switzerland / Q000453:epidemiology
references.citation: J Clin Epidemiol. 1994 Aug;47(8):891-6
references.pmid: 7730892
references.citation: Int J Clin Pharmacol Ther. 2007 Dec;45(12):643-53
references.pmid: 18184532
references.citation: Drugs Aging. 2010 Dec 1;27(12):1019-28
references.pmid: 21087071
references.citation: Drugs Aging. 2006;23(10):823-37
references.pmid: 17067185
references.citation: Health Econ. 2007 Oct;16(10):1109-26
references.pmid: 17311357
references.citation: Dtsch Arztebl Int. 2010 Aug;107(31-32):543-51
references.pmid: 20827352
references.citation: Br J Clin Pharmacol. 2010 May;69(5):543-52
references.pmid: 20573091
references.citation: Dtsch Arztebl Int. 2012 Feb;109(5):69-75
references.pmid: 22368709
references.citation: BMJ. 2004 Jul 3;329(7456):15-9
references.pmid: 15231615
references.citation: Arch Intern Med. 2003 Dec 8-22;163(22):2716-24
references.pmid: 14662625
references.citation: Am J Emerg Med. 1996 Sep;14(5):447-50
references.pmid: 8765105
references.citation: Eur J Clin Pharmacol. 2007 Aug;63(8):725-31
references.pmid: 17554532
references.citation: BMC Clin Pharmacol. 2010 Dec 02;10:16
references.pmid: 21122160
references.citation: Clin Pharmacol Ther. 2011 Jun;89(6):845-54
references.pmid: 21508941
references.citation: J Am Geriatr Soc. 2012 Apr;60(4):616-31
references.pmid: 22376048
references.citation: JAMA. 2005 Mar 16;293(11):1348-58
references.pmid: 15769968
references.citation: Drugs Aging. 2010 May;27(5):407-15
references.pmid: 20450238
references.citation: J Am Acad Nurse Pract. 2005 Apr;17(4):123-32
references.pmid: 15819637
references.citation: Drugs Aging. 2005;22(1):69-82
references.pmid: 15663350
references.citation: JAMA. 1999 Jul 14;282(2):113-5
references.pmid: 10411177
references.citation: J Am Geriatr Soc. 2001 Feb;49(2):200-9
references.pmid: 11207875
references.citation: JAMA. 2004 Sep 8;292(10):1213-20
references.pmid: 15353534
references.citation: Lancet. 2000 Oct 7;356(9237):1255-9
references.pmid: 11072960
references.citation: Arch Intern Med. 1997 Jul 28;157(14):1531-6
references.pmid: 9236554
references.citation: CMAJ. 1997 Feb 1;156(3):385-91
references.pmid: 9033421
references.citation: J Health Econ. 2000 Sep;19(5):679-95
references.pmid: 11184799
references.citation: Drugs Aging. 2007;24(1):37-55
references.pmid: 17233546
references.citation: Drugs Aging. 2010 Sep 1;27(9):747-58
references.pmid: 20809664